These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antimicrobial drug development--the past, the present, and the future. Powers JH Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():23-31. PubMed ID: 15522037 [TBL] [Abstract][Full Text] [Related]
23. History of antibiotics. From salvarsan to cephalosporins. Zaffiri L; Gardner J; Toledo-Pereyra LH J Invest Surg; 2012 Apr; 25(2):67-77. PubMed ID: 22439833 [TBL] [Abstract][Full Text] [Related]
24. Paul Ehrlich, a prescient pioneer in the field of antimicrobial chemotherapy: what did he foresee a century ago? Tillotson GS; Zinner SH Expert Rev Anti Infect Ther; 2013 Feb; 11(2):113-5. PubMed ID: 23409816 [No Abstract] [Full Text] [Related]
25. Developing new antibacterials through natural product research. Kirst HA Expert Opin Drug Discov; 2013 May; 8(5):479-93. PubMed ID: 23480029 [TBL] [Abstract][Full Text] [Related]
26. [Antibiotics - quo vadit?]. Lode HM; Stahlmann R Dtsch Med Wochenschr; 2012 Jun; 137(24):1314-6. PubMed ID: 22669701 [No Abstract] [Full Text] [Related]
27. Rifamycin S and its geometric isomer produced by a newly found actinomycete, Micromonospora rifamycinica. Huang H; Wu X; Yi S; Zhou Z; Zhu J; Fang Z; Yue J; Bao S Antonie Van Leeuwenhoek; 2009 Feb; 95(2):143-8. PubMed ID: 19125348 [TBL] [Abstract][Full Text] [Related]
28. An historical overview of drug discovery. Pina AS; Hussain A; Roque AC Methods Mol Biol; 2009; 572():3-12. PubMed ID: 20694682 [TBL] [Abstract][Full Text] [Related]
29. [A historical story of the Japanese antibiotics world-development of penicillin]. Hotta K Jpn J Antibiot; 2010 Apr; 63(2):179-204. PubMed ID: 20919498 [No Abstract] [Full Text] [Related]
30. The pleuromutilin antibiotics: a new class for human use. Novak R; Shlaes DM Curr Opin Investig Drugs; 2010 Feb; 11(2):182-91. PubMed ID: 20112168 [TBL] [Abstract][Full Text] [Related]
32. Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648. Tomioka H Arch Immunol Ther Exp (Warsz); 2000; 48(3):183-8. PubMed ID: 10912623 [TBL] [Abstract][Full Text] [Related]
33. Trends in discovery of new drugs for tuberculosis therapy. Riccardi G; Pasca MR J Antibiot (Tokyo); 2014 Sep; 67(9):655-9. PubMed ID: 25095807 [TBL] [Abstract][Full Text] [Related]
34. Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins. Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G J Infect; 2008 Jul; 57(1):78-81. PubMed ID: 18550175 [TBL] [Abstract][Full Text] [Related]
35. Epoch-making milestones in antibiotic exploratory researches in Japan. Hotta K Biosci Biotechnol Biochem; 2017 Jan; 81(1):23-27. PubMed ID: 27885928 [TBL] [Abstract][Full Text] [Related]
36. The coming of age of antibiotics: discovery and therapeutic value. Bush K Ann N Y Acad Sci; 2010 Dec; 1213():1-4. PubMed ID: 21175674 [TBL] [Abstract][Full Text] [Related]
37. Visions of drug discovery. Cimetidine (Tagamet). Mol Interv; 2009 Feb; 9(1):12-3. PubMed ID: 19299658 [No Abstract] [Full Text] [Related]
38. Antibacterial drug discovery in the 21st century. Bush K Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():10-7. PubMed ID: 15522035 [TBL] [Abstract][Full Text] [Related]
39. Preparation and in vitro anti-staphylococcal activity of novel 11-deoxy-11-hydroxyiminorifamycins. Li J; Ma Z; Chapo K; Yan D; Lynch AS; Ding CZ Bioorg Med Chem Lett; 2007 Oct; 17(20):5510-3. PubMed ID: 17826091 [TBL] [Abstract][Full Text] [Related]
40. Antibiotics: Recover the lost art of drug discovery. Lewis K Nature; 2012 May; 485(7399):439-40. PubMed ID: 22622552 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]